Downregulation of FPN1 acts as a prognostic biomarker associated with immune infiltration in lung cancer
Figure 10.Effects of FPN1 on survival based on multiple immune cell subgroups in LUAD. (A–H) Associations of FPN1 and OS in diverse immune cell subgroups in LUAD patients.